Chronic myeloid leukemia (CML) was identified as a neoplastic disease of hematopoietic stem cells, arising from a fusion event termed BCR-ABL [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.